50-12-110. Immunity from suit. A manufacturer of an investigational drug, biological product, or device, a pharmacist, a health care facility, a health care provider, or a person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device is immune from suit for any harm done to the eligible patient resulting from the investigational drug, biological product, or device if the manufacturer, pharmacist, health care facility, health care provider, or other person or entity is complying in good faith with the terms of this act and has exercised reasonable care.
History: En. Sec. 10, Ch. 135, L. 2015.
Structure Montana Code Annotated
Chapter 12. Treatments for Chronic or Terminal Illness
50-12-103. Availability of experimental drugs
50-12-104. Eligible patient -- requirements
50-12-105. Written informed consent required
50-12-106. Effect on insurance coverage and health care services
50-12-107. Heirs not liable for payments
50-12-108. Disciplinary action prohibited